Jeffrey Ludwig
Vermögen: 773 832 $ am 30.06.2026
Vermögen: 773 832 $ am 30.06.2026
Jeffrey Ludwig worked at Amgen, Inc. from 2001 to 2019, serving as Vice President-Oncology Sales from 2014 to 2019.
Then worked at Astellas Pharma, Inc. from 2019 to 2020 as Vice President-Oncology Sales.
Education includes an undergraduate degree from Arizona State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,19 % | 13.04.2026 | 95.417 ( 0,19 % ) | 773 832 $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 08.05.2025 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01.03.2020 |
| AMGEN INC. | Corporate Officer/Principal | 01.08.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen